TABLE 2.
Comparison of internal and referred patients
| Internal (n=236) | Referred (n=163) | P | Unadjusted OR (95% CI) | |
|---|---|---|---|---|
| Sex | ||||
| Female | 44 (19) | 35 (21) | 0.486 | 1.19 (0.73–1.96) |
| Male | 192 (81) | 128 (79) | 1.00 | |
| Ethnicity | ||||
| Caucasian | 143 (61) | 61 (37) | <0.001 | 1.00 |
| Other | 93 (39) | 102 (63) | 2.57 (1.71–3.88) | |
| Cirrhosis | ||||
| No | 7 (3) | 13 (8) | 0.024 | 2.83 (1.11–7.27) |
| Yes | 229 (97) | 150 (92) | 1.00 | |
| BCLC stage at treatment | ||||
| 0/A | 178 (75) | 80 (49) | <0.001 | 1.00 |
| B/C/D | 58 (25) | 83 (51) | 3.18 (2.08–4.88) | |
| Milan criteria | ||||
| No | 65 (28) | 104 (64) | <0.001 | 4.64 (3.02–7.12) |
| Yes | 171 (72) | 59 (36) | 1.00 | |
| Income quintile (postal code) | ||||
| 1 (lowest) | 56 (24) | 37 (23) | 0.734 | 1.00 |
| 2 | 53 (22) | 42 (26) | 1.20 (0.67–2.14) | |
| 3 | 41 (17) | 32 (20) | 1.18 (0.64–2.20) | |
| 4 | 39 (17) | 32 (20) | 1.24 (0.67–2.32) | |
| 5 (highest) | 36 (15) | 19 (12) | 0.80 (0.40–1.60) | |
| Unmatchable | 11 (5) | 1 (0.6) | 0.14 (0.02–1.11) | |
| Cause(s) of liver disease | ||||
| Hepatitis B virus | 58 (25) | 82 (50) | <0.001 | 2.90 (1.53–5.52) |
| Hepatitis C virus | 105 (44) | 51 (31) | 1.00 (0.52–1.90) | |
| Combined | 34 (14) | 11 (7) | 0.66 (0.28–1.59) | |
| Other/unknown | 39 (17) | 19 (12) | 1.00 | |
| Age, years | ||||
| Mean ± SD | 61.6±10.8 | 61.2±11.3 | 0.627 | 1.00 (0.98–1.01) |
| Median (range) | 61 (26–86) | 61 (31–85) | ||
| Residence | ||||
| Beyond metropolitan* | 32 (14) | 26 (16) | 0.505 | 1.21 (0.69–2.12) |
| Metropolitan* | 204 (86) | 137 (84) | 1.00 | |
Data presented as n (%) unless otherwise indicated.
*
Greater Toronto (Ontario) area. BCLC Barcelona Clinic Liver Cancer